A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. (2018)
Attributed to:
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep.29477
PubMed Identifier: 28833331
Publication URI: http://europepmc.org/abstract/MED/28833331
Type: Journal Article/Review
Volume: 67
Parent Publication: Hepatology (Baltimore, Md.)
Issue: 5
ISSN: 0270-9139